4//SEC Filing
PAYNE JOHN BERNARD 4
Accession 0001654954-24-007460
CIK 0001101026other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 6:25 PM ET
Size
14.5 KB
Accession
0001654954-24-007460
Insider Transaction Report
Form 4
PAYNE JOHN BERNARD
Director
Transactions
- Disposition to Issuer
Nonstatutory Stock Option to Purchase Common Stock
2024-06-05−31,836→ 0 totalExercise: $17.16Exp: 2032-12-15→ Common Stock (31,836 underlying) - Disposition to Issuer
Nonstatutory Stock Option to Purchase Common Stock
2024-06-05−32,000→ 0 totalExercise: $33.00Exp: 2031-10-20→ Common Stock (32,000 underlying) - Disposition to Issuer
Nonstatutory Stock Option to Purchase Common Stock
2024-06-05−1,902→ 0 totalExercise: $26.88Exp: 2031-10-11→ Common Stock (1,902 underlying) - Award
Nonstatutory Stock Option to Purchase Common Stock
2024-06-05+167,180→ 167,180 totalExercise: $7.96Exp: 2034-06-04→ Common Stock (167,180 underlying) - Award
Nonstatutory Stock Option to Purchase Common Stock
2024-06-05+50,251→ 50,251 totalExercise: $7.96Exp: 2034-06-04→ Common Stock (50,251 underlying)
Footnotes (4)
- [F1]The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023.
- [F2]The canceled options were fully vested.
- [F3]The Issuer canceled options for an aggregate 65,738 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 10/21/2021, and 12/16/2022. In exchange for the canceled options, the Reporting Person received a replacement option, for 167,180 shares, having an exercise price of $7.96.
- [F4]The option was issued pursuant to the 2021 Equity Incentive Plan and all options vested immediately upon the date of acceptance of grant.
Documents
Issuer
Zivo Bioscience, Inc.
CIK 0001101026
Entity typeother
Related Parties
1- filerCIK 0001582392
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 6:25 PM ET
- Size
- 14.5 KB